Last updated 10 months ago

A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin

970 patients around the world
Available in Argentina, Mexico
Bristol-Myers Squibb
6Research sites
970Patients around the world
This study is for people with
Esophageal cancer
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Fundación Cori para la Investigación y Prevención del Cáncer - La Rioja
Recruiting
Dorrego 269, La Rioja
Hospital Provincial del Centenario - Rosario, Santa Fe
Recruiting
Urquiza 3101, Rosario, Santa Fe
Hospital de Gastroenterología Dr.Carlos Bonorino Udaondo
Recruiting
Av. Caseros 2061, CABA, Buenos Aires
Instituto de Oncología Ángel H. Roffo - CABA, Buenos Aires
Recruiting
Av. San Martín 5481, CABA, Buenos Aires
Centro de Atención e Investigación Cardiovascular del Potosí S.C.
Recruiting
Hospital Ángeles, Antonio Aguilar 155-Piso 1 Int. L, Burocratas del Estado, 78213 San Luis Potosí, S.L.P., Mexico
Instituto Nacional de Cancerología - Ciudad de México
Recruiting
Avenida San Fernando 22, México DF
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy